Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators

US9884809B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9884809-B2
Application numberUS-201514877974-A
CountryUS
Kind codeB2
Filing dateOct 8, 2015
Priority dateDec 17, 2010
Publication dateFeb 6, 2018
Grant dateFeb 6, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are novel antioxidant inflammation modulators, including those of the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds. Methods and intermediates useful for making the compounds, and methods of using the compounds and compositions thereof are also provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of the formula: wherein: R 1 and R 2 are each methyl; and R 3 ,R 4 ,R 5 and R 6 are each independently: hydrogen, hydroxy or amino, or alkyl (c≦12) , acyl (c≦12) , alkoxy (c≦12) , aryloxy (c≦12) , alkylamino (c≦12) , dialkylamino (c≦12) , amido (c≦12) , or a substituted version of any of these groups; or a pharmaceutically acceptable salt or tautomer thereof. 2. The compound of claim 1 , wherein R 4 ,R 5 and R 6 are each hydrogen. 3. The compound of claim 1 , wherein R 3 is hydroxy. 4. The compound of claim 1 , wherein R 3 is alkoxy (c≦6) or substituted alkoxy (c≦6) . 5. The compound of claim 4 , wherein R 3 is substituted alkoxy (c≦6) . 6. The compound of claim 5 , wherein R 3 is methoxymethoxy. 7. The compound of claim 1 , wherein carbon atom 10 is in the R configuration. 8. The compound of claim 1 , wherein carbon atom 10 is in the S configuration. 9. The compound of claim 1 , wherein carbon atom 5 is in the R configuration. 10. The compound of claim 1 , wherein carbon atom 5 is in the S configuration. 11. The compound of claim 1 , further defined as:

Assignees

Inventors

Classifications

  • Free radical scavengers or antioxidants · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

  • condensed with carbocyclic rings or ring systems · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9884809B2 cover?
Disclosed herein are novel antioxidant inflammation modulators, including those of the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds. Methods and intermediates useful for making the compounds, and methods of using the compounds and compositions thereof are al…
Who is the assignee on this patent?
Reata Pharmaceuticals Inc
What technology area does this patent fall under?
Primary CPC classification C07C255/47. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).